Cytogen regulatory update

CYTO said U.S. Patent No. 5,538,866 issued to Sloan-Kettering Institute (New York, N.Y.) covering the company's prostate-specific membrane antigen ( PSMA). CYTO has an exclusive option to license the patent. ...